Page last updated: 2024-11-11

6-(6-(4-hydroxypiperidinyl)hexyloxy)-3-methylflavone hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-(6-(4-hydroxypiperidinyl)hexyloxy)-3-methylflavone hydrochloride: a potent, selective & orally active sigma site ligand; has no effect on dopamine turnover; structure fiven in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9890958
SCHEMBL ID8787810
MeSH IDM0216910

Synonyms (15)

Synonym
npc-16377
139652-86-1
4h-1-benzopyran-4-one, 6-((6-(4-hydroxy-1-piperidinyl)hexyl)oxy)-3-methyl-2-phenyl-, hydrochloride
6-(6-(4-hydroxypiperidinyl)hexyloxy)-3-methylflavone hydrochloride
npc 16377
6-(6-(4-hydroxypiperidinyl)hexyloxy)-3-methylflavone hcl
SCHEMBL8787810
DTXSID40161144
npc16377
6-[6-(4-hydroxypiperidin-1-yl)hexoxy]-3-methyl-2-phenylchromen-4-one;hydrochloride
MS-28735
CS-0437619
sigma-ligand-1 (hydrochloride)
HY-101626A
sigma-ligand-1 hydrochloride

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Using a potent and selective ligand of sigma binding sites, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), we further investigated the influence of sigma ligands on additional behavioral and toxic effects of cocaine in mice."( Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine.
Ferkany, J; Hickey, P; Katz, JL; Menkel, M; Pontecorvo, M; Terry, P; Witkin, JM, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]